Lazovskaya, L.N.: The change in respiration of blood vessels with age. Biochimia, 8: 171, 1943.
2.
Briggs, F.N. , Chernick, S., AND Chaikoff, I.L.: The metabolism of arterial tissue. I. Respiration of rat thoracic aorta. J. Biol. Chem., 179: 103, 1949 .
3.
Chernick, S. , Srere, P.A., AND Chaikoff , I.L.: The metabolism of arterial tissue. II. Lipide syntheses: The formation in vitro of fatty acids and phospholipides by rat artery with C14 and P32 as indicators. J. Biol. Chem., 179: 113, 1949.
4.
Kirk, J.E.: Metabolism of arterial tissue. J. Gerontol., 6: 167, 1951.
5.
Zilversmit, D.B., Sweeley, C.C., AND Newman, H.I.: Fatty acid composition of serum and aortic intimal lipids in rabbits fed low- and high-cholesterol diets. Circulation Res., 9: 235, 1961.
6.
Malinow, M.R. : In vitro effects of estradiol on the aorta of chickens. Circulation Res., 8: 506, 1960.
7.
Malinow, M.R. , Gimeno, A.L., Pel-Legrino-Iraldi , A.A., Fernandez-Gimeno, M.A., Lacuara, J.L., AND Moguilevsky, J.A. : The C17-OH group of œstradiol: relationships between its anti-atherogenic and endocrine actions. Nature (London), 184 (suppl. 22): 1720, 1959.
8.
Fishman, W.H. , Odell, L.D., Gill , J.E., AND Christensen , R.A.: The influence of stilbestrol on serum beta-glucuronidase in women following parturition . Am. J. Obst. & Gynec., 59: 414, 1950.
9.
Kritchevsky, D., Staple, E., Rabinowitz , J.L., AND Whitehouse , M.W.: Differences in cholesterol oxidation and biosynthesis in liver of male and female rats . Am. J. Physiol., 200: 519, 1961.
10.
Malinow, M.R. , Moguilevsky, J.A., AND Bumashny , E.: Influence of the gonads on aortic oxygen uptake in rats. J. Atherosclerosis Res., 1: 128, 1961.
11.
Pilgeram, L.O. : Deficiencies in the lipoprotein lipase in atherosclerosis . J. Gerontol., 13: 32, 1958.
12.
Kayahan, S. : Atherosclerosis and beta-glucuronidase. Lancet, 2: 667, 1960.
13.
Engelberg, H.: Plasma heparin levels. Correlation with serum cholesterol and low-density lipoproteins. Circulation, 23: 573, 1961.
14.
Kask, E.: 17-Ketosteroids and arteriosclerosis. Angiology, 10: 358, 1959.
15.
Fritz, I.B. : Factors influencing the rates of long-chain fatty acid oxidation and synthesis in mammalian systems. Physiol. Rev., 41: 52, 1961.
16.
Ahrens, E.H. , JR., Hirsch,. J., Oette, K., Farquhar, J.W., and Stein, Y.: Carbohydrate-induced and fat-induced lipemia .
17.
Corcoran, A.C. : Coronary atherosclerosis. Status of MER-29 (triparanol). Am. Heart J., 61: 431, 1961.
18.
Steinberg, D., Avigan, J., AND Feigelson, E.B.: Effects of triparanol (MER-29) on cholesterol biosynthesis and on blood sterol levels in man. J. Clin. Invest. , 40: 884, 1961.
19.
Achor, R.W.P. , Winkelmann, R.K., AND Perry, H.O.: Cutaneous side effects from use of triparanol (MER-29): Preliminary data on ichthyosis and loss of hair. Proc. Staff Meet . Mayo Clin., 36: 217, 1961.
20.
Kirk, J.E., Wang, I., AND Brandstrup, N.: The glucose-6-phosphate and 6-phosphogluconate dehydrogenase activities of arterial tissue in individuals of various ages. J. Gerontol. , 14: 25, 1959.
21.
Kirk, J.E.: The glyoxalase I activity of arterial tissue of individuals of various ages . J. Gerontol., 15: 139, 1960.
22.
Kirk, J.E.: The adenylpyrophosphatase, inorganic pyrophosphatase and phosphomonoesterase activities of human arterial tissue in individuals of various ages. J. Gerontol., 14: 181, 1959.
23.
Kirk, J.E., Matzke, J.R., Brandstrup, N., AND Wang, I.: The lactic dehydrogenase, malic dehydrogenase, and phosphoglucoisomerase activities of coronary artery tissue in individuals of various ages. J. Gerontol., 13: 24, 1958.
24.
Maier, N., AND Haimovici, H.: Metabolism of arterial tissue. Oxidative capacity of intact arterial tissue. Proc. Soc. Exper. Biol. &Med., 95: 425, 1957.
25.
Sørensen, L.B. , AND Kirk, J.E.: Variation with age in the fumarase activity of human aortic and pulmonary artery tissue. J. Gerontol. , 11: 28, 1956.
26.
Laursen, T.J.S. , AND Kirk, J.E.: The presence of aconitase and fumarase in human aortic tissue. J. Gerontol., 10: 26, 1955.
27.
Lack of enzyme leads to atheroma. Med. World News, 2: 18, 1961.
28.
Banga, I., AND Nowotny, A.: Change of the ATP-ase activity and elastin content of the arterial wall in consequence of arteriosclerosis. Acta physiol. acad. sc. Hungar. , 2: 327, 1951.
29.
Kirk, J.E., AND Dyrbye, M.: The phenolsulfatase activity of aortic and pulmonary artery tissue in individuals of various ages. J. Gerontol., 11: 129, 1956.
30.
Kirk, J.E.: The aconitase activity of arterial tissue in individuals of various ages. J. Gerontol., 16: 25, 1961.
31.
Dyrbye, M., AND Kirk, J.E.: The beta-glucuronidase activity of aortic and pulmonary artery tissue in individuals of various ages. J. Gerontol., 11: 33, 1956.
32.
Kirk, J.E., AND Sørensen, L.B.: The aldolase activity of aortic and pulmonary artery tissue in individuals of various ages. J. Gerontol., 11: 373, 1956.
33.
Chang, Y.O. , Laursen, T.J.S., AND Kirk, J.E.: The total nicotinic acid and pyridine nucleotide content of human aortic tissue. J. Gerontol., 10: 165, 1955.
34.
Parsons, W.B. , JR.: Treatment of hypercholesteremia by nicotinic acid. Arch. Int. Med., 107: 71, 1961.
35.
Parsons, W.B. , JR.: Studies of nicotinic acid use in hypercholesteremia . Arch. Int. Med., 107: 85, 1961.
36.
Bloch, K.: Lipide Metabolism, p. 12. John Wiley & Sons, Inc., New York, 1960.
37.
Schaus, R., Kirk, J.E., AND Laursen, T.J.S.: The riboflavin content of human aortic tissue. J. Gerontol. , 10: 170, 1955.
38.
Kittinger, G.W., Wexler, B.C., AND Miller, B.F.: Arteriosclerosis in the rat: Aortic enzyme changes accompanying arterial pathology. Proc. Soc. Exper. Biol. &Med., 104: 616, 1960.
39.
Pantesco, V. , Mandel, P., AND Fontaine, R.: Contribution à l'étude du métabolisme artériel et de son rôle pathogénique dans les artériopathies sclérotiques. Bull Soc. Inter. Chir., 19: 153, 1960.
40.
Baló, J., AND Banga, I.: Change in the elastase content of the human pancreas in relation to arteriosclerosis . Acta physiol. acad. sc. Hungar., 4: 187, 1953.
41.
Morrison, L.M. , Wolfson, E., AND Berlin, P.: The relationship of cholesterol esterase to atherosclerosis. Circulation, 2: 479, 1950.
42.
Rinehart, J.F. , AND Greenberg, L.D.: Arteriosclerotic lesions in pyridoxine deficient monkeys. Fed. Proc., 7: 278, 1948.
43.
Nakahara, I. , Watanabe, Y., Morino , Y., AND Sakamoto, Y.: Enzymatic studies on pyridoxine metabolism. VII. The influence of fat and fatty acid administration upon pyridoxine metabolism . J. Biochem. (Tokyo), 49: 343, 1961.
44.
Gould, R.G. , Taylor, C.B., Hagerman , J.S., Warner, I., AND Campbell, D.J.: Cholesterol metabolism. I. Effect of dietary cholesterol on the synthesis of cholesterol in dog tissue in vitro. J. Biol. Chem., 201: 519, 1953 .
45.
Bavina, M.V. , AND Alekseeva, A.S.: Changes in activity of some enzyme systems in experimental atherosclerosis induced by cholesterol. Bull. Exper. Biol. &Med.41: 245, 1956.
46.
Wertheimer, H.E., AND Ben-Tor, V.: Physiologic and pathologic influences on the metabolism of rat aorta. Circulation Res., 9: 23, 1961.
47.
Kirk, J.E.: The leucine aminopeptidase activity of arterial tissue in individuals of various ages. J. Gerontol., 15: 136, 1960.
48.
Kirk, J.E.: The 5-nucleotidase activity in normal and arteriosclerotic portions of human arterial tissue in individuals of various ages. J. Gerontol. , 14: 288, 1959.
49.
Wang, I., AND Kirk, J.E.: The enolase activity of arterial tissue in individuals of various ages. J. Gerontol., 14: 444, 1959.
50.
Kirk, J.E.: The ribose-5-phosphate isomerase activity of arterial tissue in individuals of various ages. J. Gerontol., 14: 447, 1959.
51.
Wang, I., AND Kirk, J.E.: The total glutathione content of arterial tissue in individuals of various ages. J. Gerontol., 15: 35, 1960.
52.
Lupton, C.H. , JR., Etheridge, E.M., AND McManus, J.F.A.: Histochemical studies of 5-nucleotidase activity in human aorta. I. Age and regional variations . Proc. Annual Meeting Am. Soc. Study of Arteriosclerosis , 1952 . Abstracts, p. 463.
53.
Sandler, M. , AND Bourne, G.H.: Some histochemical observations on the human aortic wall in atherosclerosis. Circulation Res , 8: 1274, 1960.
54.
Brandstrup, N., Kirk, J.E., AND Bruni, C.: The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J. Gerontol., 12: 166, 1957.
55.
Matzke, J.R. , Kirk, J.E., AND Wang, I.: The lactic and malic dehydrogenase activities of aortic and pulmonary artery tissue in individuals of various ages. J. Gerontol., 12: 279, 1957.
56.
Mandel, P., Pantesco, V., Kempf, E., AND Fontaine, R.: Activité aldolasique et phosphomonoestérasique des aortes de bovidés jeunes et âgés. C. rend. Soc. biol.153: 343, 1959 .
57.
Mandel, P., AND Kempf, E.: Activités enzymatiques des artères de Bovidés jeunes et âgés: lactodeshydrogénase, malicodeshydrogénase, transaminase. C. rend. Soc. biol., 154: 781, 1960.
58.
Severi, C., Agostini, C., AND Perin, A.: Modificazioni di alcune attività enzimatiche nell'aterosclerosi sperimentale . Sperimentale107: 69, 1957.
59.
Di Sabato, G. , AND Comolli, R.: Ricerche sul metabolismo ossidativo della parete aortica. Sperimentale, 107: 77, 1957.
60.
Kirk, J.E., AND Hansen, P.F.: The presence of carbonic anhydrase in the media of the human aorta . J. Gerontol, 8: 150, 1953.
61.
Baló, J., Banga, I., AND Josepovits, G.: Enzyme activity of the aorta. Adenylpyrophosphatase of the aorta. Ztschr. Vitamin- Hormon- u. Fermentforsch, 2: 1, 1949.
62.
Kirk, E., AND Prætorius, E.: The presence of a phosphatase in the human aortic wall. J. Lab. & Clin. Med., 34: 1617, 1949. 63. Kirk, E., AND Prætorius, E.: Presence of a phosphatase in the human aortic wall. Science111: 334, 1950.
63.
Kirk, J.E., AND Prætorius, E.: Further studies on the human aortic phosphatase. Circulation2: 477, 1950.
64.
Kirk, J.E., AND Laursen, T.J.S.: Dehydrogenase activities of human aortic tissue determined with the triphenyl tetrazolium technique. J. Gerontol, 10: 18, 1955.
65.
Kirk, J.E., Laursen, T.J.S., AND Schaus, R.: Studies on the succinic dehydrogenase of human aortic tissue. J. Gerontol., 10: 178, 1955.
66.
Kirk, J.E., Effersøe, P.G., AND Chiang, S.P.: The rate of respiration and glycolysis by human and dog aortic tissue . J. Gerontol., 9: 10, 1954.
67.
Field, H.: Dynamic aspects of cholesterol metabolism in different areas of the aorta and other tissues in man and their relationship to atherosclerosis. Circulation, 22: 547, 1960.
68.
Christie, R.W. , AND Dahl, L.K.: Dissimilarity in oxygen consumption between the thoracic and abdominal aorta in rats. J. Exper. Med., 106: 357, 1957.
69.
Fisher, E.R. , AND Geller, J.H.: Effect of cholesterol atherosclerosis, hypertension and cortisone on aortic oxygen consumption in rabbit. Circulation Res., 8: 820, 1960.
70.
Pantesco, V. , Viaud, J., Fontaine , R., AND Mandel, P.: Sur le mode de dégradation du glucose par l'aorte de Bovidés. C. rend. Soc. biol., 151: 1584, 1957 .
71.
Morris, B.: Significance of reticuloendothelial cells in atherosclerosis. Am. Heart J., 61: 569, 1961.
72.
Uotila, U., Levonen, E., AND Raekallio, J.: On the effect of atherosclerosis and goitre on aortic histopathology and mucopolysaccharide content. Acta endocrinol., 36: 1, 1961.
73.
Yu, S.Y. , AND Blumenthal, H.T.: The functional significance of mucopolysaccharides obtained from cattle aorta. J. Gerontol. , 13: 366, 1958.
74.
Dyrbye, M.O. : Studies on the metabolism of the mucopolysaccharides of human arterial tissue by means of S35, with special reference to changes related to age. J. Gerontol.14: 32, 1959.
75.
Kirk, J.E.: The isocitric dehydrogenase and TPN-malic enzyme activities of arterial tissue in individuals of various ages. J. Gerontol., 15: 262, 1960.
76.
Amenta, J.S. , AND Waters, L.L.: The precipitation of serum lipoproteins by mucopolysaccharides extracted from aortic tissue. Yale J. Biol. &Med., 33: 112, 1960.
77.
Gerö, S., Gergely, J., Devényi, T., Jakab, L., Székely, J., AND Virág, S.: Role of intimal mucoid substances in the pathogenesis of atherosclerosis. I. Complex formation in vitro between mucopolysaccharides from atherosclerotic aortic intimas and plasma β-lipoprotein and fibrinogen. J. Atherosclerosis Res., 1: 67, 1961.
78.
Murata, K.: Inhibitory effect of sulfated mono- and polysaccharides on experimental hyperlipemia and atherosclerosis in rabbits. Japanese Heart J., 2: 198, 1961.
79.
Kirk, J.E., AND Laursen, T.J.S.: Diffusion coefficients of various solutes for human aortic tissue, with special reference to variation in tissue permeability with age. J. Gerontol., 10: 288, 1955.
80.
Migicovsky, B.B.: In vivo inhibition of cholesterol biosynthesis by a mitochondrial extract. Canadian J. Biochem. &Physiol ., 39: 747, 1961.
81.
Migicovsky, B.B.: Inhibition of Cholesterol Biosynthesis by a Mitochondrial Extract. Canad. J. Biochem. &Physiol ., 38: 339, 1960.
82.
Placer, Z., AND Slabochová, Z.: Inhibition of the lipoxidase system by serum proteins. Biochim. et biophys. acta, 48: 427, 1961.
83.
Orekhovich, V.N., AND Plotnikov , N.E.: On the specific effect of glycerol on the walls of the blood vessels. Arch. Biochem. &Biophys., 93: 180, 1961.
84.
Wolf, R.L., Mendlowitz, M., Gitlow, S.E., AND Naftchi, N.: Metabolism of angiotensin II-I131 in normotensive and hypertensive human subjects . Circulation, 13: 754, 1961.
85.
Havel, R.J. , AND Gordon, R.S., JR.: Idiopathic hyperlipemia: Metabolic studies in an affected family. J. Clin. Invest. , 39: 1777, 1960.
86.
Gutman, A.B. : A view of gout as an inborn error of metabolism . Am. J. Med., 29: 545, 1960.
87.
Vasolastine. Manufacturer Enzypharm C. V., Soestdijk (Holland). Indications and Posology. (Package leaflet). World Distributors: Polypharm N. V., Rotterdam.
88.
Vasolastine. (Introductory brochure.) Enzypharm, Soestdijk, Holland; and Polypharm, Rotterdam, 1957.
89.
Vaselastica. (Introductory brochure). Polypharm, N. V., Rotterdam, 1958.
90.
Bloch, K.: Lipide Metabolism, p. 14. John Wiley & Sons, Inc., New York, 1960.
91.
Yasunobu, K.T. , Peterson, E.W., AND Mason, H.S.: The oxidation of tyrosine-containing peptides by tyrosinase. J. Biol. Chem. , 234: 3291, 1959 .
92.
Schroeder, H.A. : The effect of tyrosinase on arterial hypertension . Science, 93: 116, 1941.
93.
Schroeder, H.A. , AND Adams, M.H.: The effect of tyrosinase on experimental hypertension. J. Exper. Med., 73: 531, 1941.
94.
Burn, J.H., AND Robinson, J.: Noradrenaline and adrenaline in vessels of the rabbit ear in relation to the action of amine oxidase. Brit. J. Pharmacol., 6: 101, 1951.
95.
Hayano, M., AND Dorfman, R.I.: Studies on the inhibition of various enzymes by steroids. Ann. New YorkAcad. Sc., 54: 608, 1951.
96.
Puig Muset, P., Torner, M., Morató , J.M., Valdecasas, F.G., Laporte, J., AND Busquets, J.: Lipoxidase and blood pressure. Lancet, 2: 51, 1960.
97.
Valdecasas, F.G., Laporte, J., AND Puig Muset , P.: Some actions of lipoxidase upon blood pressure. I. Med. Exper., 2: 30, 1960.
98.
Martin, J., Valdecasas, F.G., Laporte, J., AND Puig Muset, P.: Some actions of "lipoxidase" upon blood pressure. II. About the fractionation of soybean proteins. Med. Exp., 3: 272, 1960.
99.
Valdecasas, F.G., Laporte, J., Fer-Nandez , N., AND Puig Muset , P.: Some actions of "lipoxidase" upon blood pressure. III. Hypotensive action and antihypertensive activity . Med. Exp., 3: 289, 1960.
100.
Dillard, M.G. , Henick, A.S., AND Koch, R.B.: Differences in reactivity of legume lipoxidases . J. Biol. Chem., 236: 37, 1961.
101.
Schulze, G. : Uber die Wirkung von körperfremden Fermentkomplexen des Fettsäuremetabolismus auf die Blutfette beim Menschen. Deutsches Arch. klin. Med., 204: 584, 1958.
102.
Altschul, R.: Einfluss von Cytochrom C und Hämatoporphyrin auf Serumcholesterin. Ztschr. Kreislaufforsch., 48: 844, 1959.
103.
Cromoci, cytochrome c. (Package leaflet). Laboratoire Produits Biologiques Braglia S. A., Lugano. Distributor: Medicina S. A., Geneva.
104.
Seifter, J. , AND Others: Effect of hyaluronidase on experimental hypercholesterolemia in rabbits and rats and atheromatosis in rabbits. Proc. Soc. Exper. Biol. &Med., 83: 468, 1953.
105.
Banga, I., AND Baló, J.: The elasticity-increasing property of elastomucoproteinase. Biochim. et biophys. acta, 40: 367, 1960.
Altschul, R., AND Moroz, R.: Influence of glutathione on serum cholesterol in rabbitsExperientia, 16: 543, 1960.
108.
Clarke, N.E. , SR.: Atherosclerosis, occlusive vascular disease and EDTA. Am. J. Cardiol., 6: 233, 1960.
109.
Hunter, J.D. : Nicotinic acid therapy in patients with coronary disease. New Zealand M. J., 59: 280, 1960.
110.
Hoogerwerf, S.: De invloed van Vasolastine op kunstmatig gescleroseerde ratten, op honden en mensen met arteriosclerose verschijnselen . Geneesk. Gids, 33: 85, 1955.
111.
Hoogerwerf, S.: Der Einfluss von Vasolastine auf künstliche Sklerose bei Ratten und Arteriosklerose beim Menschen. Ärztl. Forsch., 9: 540, 1955.
112.
Hjelmman, G., AND Pettersson , T.: Försök med enzymbehandling av experimentell ateroskleros. Finska läk-slälsk. handl., 100: 52, 1957.
113.
Krüskemper, H.L., AND Schulze, G.: Versuche zur Verhinderung der unter Cholinmangel entstehenden Fettleber durch Behandlung mit Fermenten des Fettstoffwechsels . Arch. exper. Path. u. Pharmakol., 229: 34, 1956.
114.
Thurnherr, A., AND Koch, J.: Gefässelastizitätsbestimmung und Enzymtherapie der Arteriosklerose. Helvet. med. acta, 24: 342, 1957.
115.
Grundel, A. : Einfluss der Enzymbehandlung auf sklerosierende Prozesse. Medizinische, 49: 2011, 1958.
116.
Hammerl, H. , Klein, K., AND Siedek, H.: Zur Fermenttherapie der arteriosklerotischen Erkrankungen. Ärztl. Forsch., 13: 300, 1959.
Hammerl, H. , AND Siedek, H.: Zur Fermenttherapie der Atherosklerose (Vaselastica) . Wien. klin. Wchnschr., 68: 754, 1956.
119.
Fiegel, G. , AND Recknagel, K.: Vaselastica —Ein Versuch enzymatischer Beeinflussung der Hypertonie. Medizinische, No. 31/32: 1093, 1955.
120.
Buschmann, W.: Zur Therapie des hohen Blutdruckes. Ztschr. ges. inn. Med., 14: 711, 1959.
121.
Brouwer, M. : Erfahrungen über die Verwendung eines neuen Heilmittels gegen die Arterienverkalkung. Berliner Gesundheitsblatt , 1: 8, 1955.
122.
Barthlen, M.: Über die Behandlung der Arteriosklerose und Hypertension mit Vaselastica. Ars Medici, 49: 113, 1959.
123.
Fischer, E.K. : Ein Beitrag zur enzymologischen Behandlung der Cerebralsklerose bei Schadel-Hirnverletzten. Med. Klin.51: 649, 1956.
124.
Willinge Wittermans, A.: Nieuwe therapeutische mogelij kheden bij arteriosclerosis cerebri. Belg. tijdschr. geneesk. , 12: 480, 1956.
125.
Bacaner, M. , Connolly, J.E., AND Bruns. D.: The coronary blood flow as a critical determinant of cardiac performance and cardiac size . Am. J. Med., 30: 392, 1961.
126.
Dock, W.: The value of lateral ballistocardiograms in differentiating aortic tortuosity from myocardial dysfunction. Am. J. Med. Sc., 228: 125, 1954.
127.
Dock, W., Mandelbaum, H., AND Mandelbaum, R.A. : Ballistocardiography, pp. 29—31. The C. V. Mosby Company, St. Louis, 1953.
128.
Dock, W., Mandelbaum, H., AND Mandelbaum, R.A. : Ballistocardiography, p. 117. The C. V. Mosby Company, St. Louis, 1953.
129.
Dreyfuss, F. : The role of hyperuricemia in coronary heart disease. Dis. Chest, 38: 332, 1960.
130.
Clavind, J. , Hartmann, S., Clemmesen , J., Jessen, K.E., AND Dam, H.: Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atheroclerotic aorta . Acta path. & microbiol. scandinav, 30: 1, 1952.
131.
Harman, D. : Atherosclerosis: A hypothesis concerning the initiating steps in pathogenesis. J. Gerontol, 12: 199, 1957.
132.
Bernheim, F., Wilbur, K.M., and Kenas-Ton , C.B.: The effect of oxidized fatty acids on the activity of certain oxidative enzymes. Arch. Biochem. &Biophys., 38: 177, 1952.
133.
Mandel, P. , Pantesco, V., AND Viaud, J.: Métabolisme artériel, vieillissement et athérome . C. rend. Acad. sci., 246: 2062, 1958.
134.
Fontaine, R., Mandel, P., Pantesco , V., AND Kempf, E.: Le métabolisme de la paroi artérielle et ses variations au cours du vieillissement. Strasbourg Méd. , 11: 605, 1960.
135.
Green, D.E. , AND Lester, R.L.: Role of lipides in the mitochondrial electron transport system. Fed. Proc., 18: 987, 1959.
136.
Igo, R.P., Mackler, B., Duncan, H., Ridyard, J.N., AND Hanakau, D.J.: Cytochrome C oxidase: the effects of lipides and surface active agents on enzyme activity. Biochim. et Biophys. Acta, 42: 55, 1960.
137.
Barber, A.A. : Inhibition of lipid peroxide formation by vertebrate blood serum. Arch. Biochem., 92: 38, 1961.
138.
Swell, L., Field, H., JR., AND Treadwell, C.R.: Lipid fatty acid composition of several areas of the aorta in subjects with atherosclerosis. Proc. Soc. Exper. Biol. & Med., 105: 662, 1960.
139.
Bertelsen, S.: Alterations in human aorta and pulmonary artery with age. Acta path. & microbiol. scandinav., 51: 206, 1961.
140.
Bertelsen, S.: Histochemical investigations on plaques in human atherosclerotic aortae. Acta path. & microbiol. scandinav., 51: 229, 1961.
141.
Leites, S.M. : Some aspects of cholesterol metabolism. Biochimia, 8: 283, 1943.
142.
Mead, J.F. , AND Gouze, M.L.: Alterations in aorta lipids with advancing atherosclerosis. Proc. Soc. Exper. Biol. &Med., 106: 4, 1961.
143.
Wills, E.D. : Effect of unsaturated fatty acids and their peroxides on enzymes. Biochem. Pharmacol., 7: 7, 1961.
144.
Banks, A., Eddie, E., AND Smith, J.G.M.: Reactions of cytoehrome-c with methyl linoleate hvdroperoxide. Nature (London), 190: 908, 1961.
145.
Drury, A.: Lipolytic activity of aorta of young and old rats and influence of heparin in vivo. J. Gerontol., 16: 114, 1961.
146.
Böhle, E., AND Steigerwald, H.: Untersuchungen über den intermediären Fettstoffwechsel bei der Arteriosclerose . Klin. Wchnschr., 39: 575, 1961.
147.
Lange, R.: Inhibiting effect of tobacco smoke on some crystalline enzymes. Science, 134: 52, 1961.
148.
Israel Group Can Absorb Fat, and Contract Little Lipidemia (News item). M. Tribune, 2: 20, June 12, 1961.
149.
Altand, P.D. , AND Highman, B.: Effects of exercise on serum enzyme values and tissues of rats. Am. J. Physiol., 201: 393, 1961 .
150.
Adams, C.W. , AND Tuqan, N.A.: Elastic degeneration as a source of lipids in the early lesion of atherosclerosis. J. Path. & Bact. , 82: 131, 1961.
151.
Christensen, S.: Plasma phospholipid and phosphoprotein transfer across the intimal surface of the normal and slightly atherosclerotic thoracic aorta of the cockerel. J. Atheroscler. Res., 1: 140, 1961.
152.
Newman, H.A.I. , McCandless, E.L., AND Zilversmit , D.B.: The synthesis of C14lipids in rabbit atheromatous lesions. J. Biol. Chem. , 236: 1264, 1961.
153.
Weigensberg, B.I., McMillan, G.C., AND Ritchie, A.C.: Elaidic acid: Effect on experimental atherosclerosis . Arch. Path., 72: 358, 1961.
154.
Balakrishna, AndZaidi, S.H.: Serum histaminase activity in experimental atherosclerosis. J. Sc. & Indust. Res., 20C: 65, 1961.
155.
Hall, D.: The possible implications of enzymes of the elastase complex in atherosclerosis . J. Atheroscler. Res., 1: 173, 1961.
156.
Whereat, A.F. : Oxygen consumption of normal and atherosclerotic intima. Circulation Res., 9:571,1961.
157.
Lojda, Z., AND Zemplényi, T.: Histochemistry of some enzymes of the vascular wall in experimental rabbit atheromatosis. J. Atheroscler. Res., 1: 101, 1961.
158.
Levonen, E. , Raekallio, J., AND Uotila, U.: Histochemical demonstration of some hydrolytic enzymes in atheromatous aortas. Nature (London), 188: 677, 1960.
159.
Kirk, J.E. : The purine nucleoside phosphorylase activity of arterial tissue in individuals of various ages. J. Gerontol. , 16: 243, 1961.
160.
Ostrovsky, Y.M.: Cholesterol metabolism process of acetylation and thiamine. Bjull. Eksper. Biol. &Med., 52: 62 (No. 7), 1961.
161.
Rangam, C.M. , AND Gupta, J.C.: A correlated study of serum magnesium, cholesterol, lipid phosphorus and calcium in human beings and rabbits . Indian J. M. Res., 49: 236, 1961.
162.
Yamanaka, T. , Ota, A., AND Okunuki, K.: Activation of Pseudomonas cytochrome oxidase by catalase. J. Biochem. (Tokyo), 49: 414, 1961.
163.
Yamada, K.: Treatment of arteriosclerosis. Vitamins and sulfuric esters of polysaccharides . Jap. Heart J., 2: 281,1961.
164.
Wago, K.: Antiatherosclerotic and anticoagulant activity of cerebroside sulfate . Jap. Heart J., 2: 354,1961.
165.
Mendlowitz, M., Gitlow, S.E., AND Naftchi, N.: The etiology of hypertension. J. Mt. Sinai Hosp. New York, 28: 101, 1961.
166.
Fedoseev, A.N.: Some specific features in the reactivity of the arteries accompanying the experimental involution of cholesterol aterosclerosis in dogs. Doklady Akad. Nauk SSSR, 139: 1262, 1961 .